Equities

CUC Inc

9158:TYO

CUC Inc

Actions
  • Price (JPY)1,747.00
  • Today's Change-42.00 / -2.35%
  • Shares traded72.90k
  • 1 Year change-34.13%
  • Beta--
Data delayed at least 20 minutes, as of Nov 15 2024 02:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

CUC Inc is a Japan-based company primarily engaged in the medical institution support business and the home health care nursing business. The Company operates its business through two segments. The Medical Institution Support segment provides various operational support to medical institutions, mainly in the areas of management strategy support, business management support, and personnel and labor management support. The Home Health Care Nursing segment provides home health care nursing services, including the operation of home health care nursing stations and home hospices. The Company is also engaged in dispensing pharmacy services and sales services of ophthalmic materials and eyeglass supplies.

  • Revenue in JPY (TTM)39.29bn
  • Net income in JPY3.57bn
  • Incorporated2014
  • Employees3.74k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
9158:TYO since
announced
Transaction
value
Noah Konzer Co LtdAnnounced25 Sep 202425 Sep 2024Announced17.80%37.01m
Data delayed at least 20 minutes, as of Nov 15 2024 02:30 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
StemCell Institute Inc2.64bn423.14m17.01bn98.0040.205.9330.966.4441.3041.30257.79280.150.403925.621.6726,953,570.006.474.2315.3010.8563.4264.4016.0210.411.30----0.0018.6416.6357.0416.8446.68--
Saint-Care Holding Corp55.09bn1.74bn18.08bn4.74k10.371.108.780.328169.7469.742,208.77657.561.83383.106.3311,627,200.005.785.917.797.9912.3312.933.163.222.2420.740.234731.532.865.6317.0416.58-3.2012.30
CellSource Co Ltd4.45bn622.21m22.60bn151.0036.133.6630.655.0831.5831.58224.78311.550.74835.989.9429,442,380.0010.4719.2311.3722.5764.6470.7514.0020.2110.25--0.0012.895.5430.04-9.3036.7070.54--
Falco Holdings Co Ltd43.05bn1.83bn25.75bn1.12k13.730.956812.750.5982169.32169.323,990.492,428.931.1817.597.2538,538,940.005.025.796.417.9530.2731.284.254.662.29--0.020838.78-8.33-0.5259-26.3220.600.893711.70
Cyberdyne Inc4.46bn-1.80bn25.84bn227.00--0.9693--5.79-8.51-8.5121.14193.950.08722.047.6419,660,790.00-3.80-1.14-3.87-1.1654.4361.14-43.54-20.6814.61-11.870.0149--32.3820.57-395.30---22.40--
I'rom Group Co Ltd17.89bn258.00m32.01bn1.03k121.752.4821.761.7921.3121.311,477.811,044.220.5013.395.9917,387,760.000.7216.941.109.8739.6343.171.4411.341.1510.210.594831.02-3.3310.89-44.349.1816.6114.87
Charm Care Corp47.69bn4.45bn40.63bn2.03k9.142.217.510.852135.95135.951,458.21561.971.026.2315.0223,549,140.009.567.9217.9212.7418.1517.369.338.370.77997.630.424721.6626.2423.6333.3733.4744.0951.57
Sunwels Co Ltd23.37bn2.16bn44.80bn2.44k17.915.1414.581.9271.0171.01769.17247.450.88181,314.166.099,597,947.008.15--9.93--29.71--9.24--1.135.540.7342--55.72--159.16------
Elan Corp45.85bn2.46bn46.24bn378.0018.743.8815.351.0140.7340.73758.28196.492.4522.8510.01121,287,400.0013.1413.9022.0425.2723.0624.665.375.701.7253.110.010930.1514.2317.3920.9423.8213.7930.01
Solasto Corp136.54bn302.00m47.28bn33.88k154.462.1413.320.34623.233.231,476.44233.331.831,453.958.944,029,749.000.40375.400.59758.1816.4117.090.22122.941.3822.580.509254.163.099.91-28.85-8.4316.201.03
Value HR Co Ltd7.68bn892.35m50.59bn676.0054.577.2340.476.5833.8433.84290.32255.420.487977.5912.1011,364,460.005.664.837.456.7538.4740.5411.6112.791.36--0.455851.7615.1114.6210.1331.90-40.8531.95
CUC Inc39.29bn3.57bn54.94bn3.74k15.061.9213.401.40121.62121.621,340.36952.850.6091276.504.4210,496,660.005.52--6.40--48.98--9.06--2.49--0.539---6.21--7.10------
Amvis Holdings Inc42.48bn7.44bn91.64bn2.97k12.322.759.872.1675.8175.81432.90339.390.6671,373.785.73--11.6811.8314.4414.4640.1641.0317.5117.941.3329.560.48876.0932.8051.2317.8865.3068.3239.77
Data as of Nov 15 2024. Currency figures normalised to CUC Inc's reporting currency: Japanese Yen JPY

Institutional shareholders

10.21%Per cent of shares held by top holders
HolderShares% Held
Rheos Capital Works, Inc. (Investment Management)as of 28 Jun 20241.31m4.36%
Fidelity Management & Research (Hong Kong) Ltd.as of 31 Aug 2024326.10k1.09%
Tokio Marine Asset Management Co., Ltd.as of 18 Jan 2024324.30k1.08%
Fidelity Management & Research (Japan) Ltd.as of 30 Sep 2024302.10k1.01%
Asset Management One Co., Ltd.as of 30 Jun 2024301.10k1.00%
Simplex Asset Management Co., Ltd.as of 03 Oct 2024146.20k0.49%
abrdn Investments Ltd.as of 31 Jul 2024132.10k0.44%
Norges Bank Investment Managementas of 30 Jun 2024126.70k0.42%
Schroder Investment Management (Japan) Ltd.as of 30 Jun 202459.20k0.20%
Matthews International Capital Management LLCas of 30 Apr 202438.80k0.13%
More ▼
Data from 30 Jun 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.